Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2021) 77 OP5.1 | DOI: 10.1530/endoabs.77.OP5.1

SFEBES2021 Oral Poster Presentations Bone and Calcium (4 abstracts)

Parathyroid hormone (PTH) of 1.6 pmol/l or more at 6 months is associated with delayed recovery of parathyroid function in post-surgical hypoparathyroidism (PoSH)

Muhammad Fahad Arshad 1,2 , Amardass Dhami 2 , Gillian Quarrell 2 & Saba P Balasubramanian 1,2


1University of Sheffield, Sheffield, United Kingdom; 2Sheffield Teaching Hospitals, Sheffield, United Kingdom


Introduction: Post-surgical hypoparathyroidism (PoSH) is common after thyroidectomy. Most cases recover within 6 months, but several require long-term supplementation with calcium and activated vitamin D. When PoSH persists beyond 6 months, it is considered to be ‘long-term’ or ‘permanent’. However, few studies have demonstrated recovery beyond this time period.

Aim: Aim of this study is to determine the frequency of late recovery in this group and factors that can predict this.

Methods: Adult patients undergoing total or completion thyroidectomy between 2009-2018 were included in this cohort prospective observational study. Records of patients who met certain inclusion criteria (started on calcium or activated vitamin D, or day 1 adjusted calcium <2.1 mmol/l, or day 1 PTH <1.6 pmol/l) were reviewed to identify those with PoSH at 6 months. Demographic, biochemical, surgical, pathological, and clinical follow-up data is described and analysed.

Results: Out of 911 patients undergoing thyroidectomy, 270 met inclusion criteria. Of these, 192 were started on supplements and 138 (71.9%) recovered within six months. From the remaining 54 patients (females: males=46:8), 21 had ongoing PoSH (minimum follow-up 3 years, median follow-up 4.5 years). However, a significant number of patients (n = 19 [47.5%]) were weaned off all supplements and achieved remission (median recovery at 1.3 years, most delayed recovery at 4.8 years). All of those who recovered had a PTH of ≥1.6 pmol/l at/beyond 6 months. There was no difference in age, gender, diagnosis, type/extent of surgery, or calcium levels between the two groups.

Conclusions: Recovery from PoSH is common beyond 6 months, raising the question of whether 6-month threshold to define long-term PoSH is appropriate? In patients with PTH level of ≥1.6 pmol/l at/after 6 months, the chances of recovery are high. Therefore, attempts should be made to wean off supplements in this group.

Volume 77

Society for Endocrinology BES 2021

Edinburgh, United Kingdom
08 Nov 2021 - 10 Nov 2021

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.